Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care reality

Detalhes bibliográficos
Autor(a) principal: Fernandes Silva , Joana
Data de Publicação: 2019
Outros Autores: Custódio, Sandra, Fraga, João
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://onco.news/index.php/journal/article/view/34
Resumo: Medication adherence is vital to the success of the treatment plan, being the priority of healthcare professionals to reduce the weak links that lead to medication errors and severe damage that they can cause. Based on the European profile of patients with castrate-resistant metastatic prostate cancer, the population under oral antineoplastic therapy for this pathology at Centro Hospitalar de Vila Nova de Gaia/Espinho (CHVNG/E) during the year 2017 was characterized. In order to respond to the specific needs of this patient group, we proposed a model of adherence consultation. It is our opinion that the promotion and monitoring of the compliance must be operationalized by professionals with specialized training and motivated for this subject. The adherence consultation model is patient centric, being essential its empowerment and motivation for the therapeutic plan. With this approach we intend to enhance the quality of care and achieve health gains.
id RCAP_794c8fa416242700fdf0e27aff7131cc
oai_identifier_str oai:oai.onco.news:article/34
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care realityAdesão à terapêutica oral em doentes com cancro da próstata metastático resistente à castração (CPMRC) – Realidade do serviço de H. Dia do Centro Hospitalar Gaia/EspinhoAdesãoMotivaçãoCapacitaçãoTerapêutica oral antineoplásicaAdherenceMotivationEmpowermentOral antineoplastic therapyMedication adherence is vital to the success of the treatment plan, being the priority of healthcare professionals to reduce the weak links that lead to medication errors and severe damage that they can cause. Based on the European profile of patients with castrate-resistant metastatic prostate cancer, the population under oral antineoplastic therapy for this pathology at Centro Hospitalar de Vila Nova de Gaia/Espinho (CHVNG/E) during the year 2017 was characterized. In order to respond to the specific needs of this patient group, we proposed a model of adherence consultation. It is our opinion that the promotion and monitoring of the compliance must be operationalized by professionals with specialized training and motivated for this subject. The adherence consultation model is patient centric, being essential its empowerment and motivation for the therapeutic plan. With this approach we intend to enhance the quality of care and achieve health gains.A adesão à terapêutica é fundamental para o sucesso do tratamento instituído, sendo uma prioridade dos profissionais de saúde reduzir os pontos fracos que levam a erros de medicação e graves danos que daí advêm. Tendo por referência o perfil europeu dos doentes com Cancro da Próstata Metastático Resistente à Castração (CPmRC), caracterizou-se a população sob terapêutica oral antineoplásica para esta patologia no Centro Hospitalar de Vila Nova de Gaia/Espinho (CHVNG/E), durante o ano de 2017. Para dar resposta às necessidades específicas deste grupo de doentes, propôs-se um modelo de consulta de adesão. É nossa opinião que a promoção da adesão e a monitorização da compliance devem ser operacionalizadas por profissionais com formação especializada e motivados para esta temática. O modelo de consulta de adesão tem como pilar central o doente, sendo fundamental a sua capacitação e motivação para o plano terapêutico. Com esta abordagem pretendemos potenciar a qualidade dos cuidados e obter ganhos em saúde.AEOP – Associação de Enfermagem Oncológica Portuguesa2019-12-20info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://onco.news/index.php/journal/article/view/34Onco.news; No. 39 (2019): Onco.News Journal (july-december); 12-16Onco.News; N.º 39 (2019): Revista Onco.News (julho-dezembro); 12-162183-69141646-7868reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://onco.news/index.php/journal/article/view/34https://onco.news/index.php/journal/article/view/34/56Direitos de Autor (c) 2019 Joana Fernandes Silva , Sandra Custódio, João Fragainfo:eu-repo/semantics/openAccessFernandes Silva , JoanaCustódio, SandraFraga, João2024-03-16T07:55:11Zoai:oai.onco.news:article/34Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T04:01:19.507124Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care reality
Adesão à terapêutica oral em doentes com cancro da próstata metastático resistente à castração (CPMRC) – Realidade do serviço de H. Dia do Centro Hospitalar Gaia/Espinho
title Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care reality
spellingShingle Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care reality
Fernandes Silva , Joana
Adesão
Motivação
Capacitação
Terapêutica oral antineoplásica
Adherence
Motivation
Empowerment
Oral antineoplastic therapy
title_short Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care reality
title_full Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care reality
title_fullStr Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care reality
title_full_unstemmed Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care reality
title_sort Adherence to oral therapeutic in patients with castrate-resistant metastatic prostate cancer – Centro Hospitalar Gaia/Espinho Day Care reality
author Fernandes Silva , Joana
author_facet Fernandes Silva , Joana
Custódio, Sandra
Fraga, João
author_role author
author2 Custódio, Sandra
Fraga, João
author2_role author
author
dc.contributor.author.fl_str_mv Fernandes Silva , Joana
Custódio, Sandra
Fraga, João
dc.subject.por.fl_str_mv Adesão
Motivação
Capacitação
Terapêutica oral antineoplásica
Adherence
Motivation
Empowerment
Oral antineoplastic therapy
topic Adesão
Motivação
Capacitação
Terapêutica oral antineoplásica
Adherence
Motivation
Empowerment
Oral antineoplastic therapy
description Medication adherence is vital to the success of the treatment plan, being the priority of healthcare professionals to reduce the weak links that lead to medication errors and severe damage that they can cause. Based on the European profile of patients with castrate-resistant metastatic prostate cancer, the population under oral antineoplastic therapy for this pathology at Centro Hospitalar de Vila Nova de Gaia/Espinho (CHVNG/E) during the year 2017 was characterized. In order to respond to the specific needs of this patient group, we proposed a model of adherence consultation. It is our opinion that the promotion and monitoring of the compliance must be operationalized by professionals with specialized training and motivated for this subject. The adherence consultation model is patient centric, being essential its empowerment and motivation for the therapeutic plan. With this approach we intend to enhance the quality of care and achieve health gains.
publishDate 2019
dc.date.none.fl_str_mv 2019-12-20
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://onco.news/index.php/journal/article/view/34
url https://onco.news/index.php/journal/article/view/34
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://onco.news/index.php/journal/article/view/34
https://onco.news/index.php/journal/article/view/34/56
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2019 Joana Fernandes Silva , Sandra Custódio, João Fraga
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2019 Joana Fernandes Silva , Sandra Custódio, João Fraga
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv AEOP – Associação de Enfermagem Oncológica Portuguesa
publisher.none.fl_str_mv AEOP – Associação de Enfermagem Oncológica Portuguesa
dc.source.none.fl_str_mv Onco.news; No. 39 (2019): Onco.News Journal (july-december); 12-16
Onco.News; N.º 39 (2019): Revista Onco.News (julho-dezembro); 12-16
2183-6914
1646-7868
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138187163992064